Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03261947
Title A Study to Evaluate the Safety, Tolerability, and Activity of TAK-931 in Participants With Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer, and Other Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Millennium Pharmaceuticals, Inc.
Indications

colon adenocarcinoma

pancreatic adenocarcinoma

rectum adenocarcinoma

lung squamous cell carcinoma

esophagus squamous cell carcinoma

Therapies

Simurosertib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.